Glycosylation and Cardiovascular Diseases

Area of Science:

• Biochemistry
• Immunology
• Cardiovascular Medicine

Background:

• Cardiovascular disease (CVD) remains the leading global cause of mortality, with coronary artery disease and stroke as primary drivers.
• Recent advancements enable the investigation of glycans and protein glycosylation patterns in relation to CVD.
• Existing research indicates significant associations between glycans and systemic inflammation, key CVD risk factors, and clinical outcomes.

Purpose of the Study:

• To explore the potential of glycans as biomarkers for cardiovascular disease (CVD) risk prediction.
• To evaluate the utility of glycans in monitoring therapeutic responses and lifestyle modifications in CVD patients.
• To understand how glycans encapsulate complex biological information relevant to CVD.

Main Methods:

• Analysis of glycan structures and glycosylation patterns.
• Correlation studies linking glycan profiles with CVD risk factors and events.
• Investigation of glycan responsiveness to anti-inflammatory therapies and lifestyle interventions.

Main Results:

• Glycans are significantly associated with systemic inflammation and major CVD risk factors.
• Glycan patterns show correlations with clinical CVD events.
• Preliminary evidence suggests glycans can monitor responses to anti-inflammatory treatments and lifestyle changes.

Conclusions:

• Glycans serve as valuable biomarkers, integrating information from inflammatory, immune, and signaling pathways.
• Glycans hold significant promise for improving CVD risk prediction.
• Glycans offer a potential tool for monitoring therapeutic interventions and lifestyle impacts in CVD management.